269 related articles for article (PubMed ID: 16809611)
1. BCL11B participates in the activation of IL2 gene expression in CD4+ T lymphocytes.
Cismasiu VB; Ghanta S; Duque J; Albu DI; Chen HM; Kasturi R; Avram D
Blood; 2006 Oct; 108(8):2695-702. PubMed ID: 16809611
[TBL] [Abstract][Full Text] [Related]
2. BCL11B enhances TCR/CD28-triggered NF-kappaB activation through up-regulation of Cot kinase gene expression in T-lymphocytes.
Cismasiu VB; Duque J; Paskaleva E; Califano D; Ghanta S; Young HA; Avram D
Biochem J; 2009 Jan; 417(2):457-66. PubMed ID: 18831712
[TBL] [Abstract][Full Text] [Related]
3. Protein Kinase C-Mediated Phosphorylation of BCL11B at Serine 2 Negatively Regulates Its Interaction with NuRD Complexes during CD4+ T-Cell Activation.
Dubuissez M; Loison I; Paget S; Vorng H; Ait-Yahia S; Rohr O; Tsicopoulos A; Leprince D
Mol Cell Biol; 2016 Jul; 36(13):1881-98. PubMed ID: 27161321
[TBL] [Abstract][Full Text] [Related]
4. BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter.
Cismasiu VB; Adamo K; Gecewicz J; Duque J; Lin Q; Avram D
Oncogene; 2005 Oct; 24(45):6753-64. PubMed ID: 16091750
[TBL] [Abstract][Full Text] [Related]
5. Bcl11b represses a mature T-cell gene expression program in immature CD4(+)CD8(+) thymocytes.
Kastner P; Chan S; Vogel WK; Zhang LJ; Topark-Ngarm A; Golonzhka O; Jost B; Le Gras S; Gross MK; Leid M
Eur J Immunol; 2010 Aug; 40(8):2143-54. PubMed ID: 20544728
[TBL] [Abstract][Full Text] [Related]
6. BCL11B is required for positive selection and survival of double-positive thymocytes.
Albu DI; Feng D; Bhattacharya D; Jenkins NA; Copeland NG; Liu P; Avram D
J Exp Med; 2007 Nov; 204(12):3003-15. PubMed ID: 17998389
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of BCL11B expression leads to apoptosis of malignant but not normal mature T cells.
Grabarczyk P; Przybylski GK; Depke M; Völker U; Bahr J; Assmus K; Bröker BM; Walther R; Schmidt CA
Oncogene; 2007 May; 26(26):3797-810. PubMed ID: 17173069
[TBL] [Abstract][Full Text] [Related]
8. Bcl11b prevents the intrathymic development of innate CD8 T cells in a cell intrinsic manner.
Hirose S; Touma M; Go R; Katsuragi Y; Sakuraba Y; Gondo Y; Abe M; Sakimura K; Mishima Y; Kominami R
Int Immunol; 2015 Apr; 27(4):205-15. PubMed ID: 25422283
[TBL] [Abstract][Full Text] [Related]
9. Expression of TCR alpha beta partly rescues developmental arrest and apoptosis of alpha beta T cells in Bcl11b-/- mice.
Inoue J; Kanefuji T; Okazuka K; Watanabe H; Mishima Y; Kominami R
J Immunol; 2006 May; 176(10):5871-9. PubMed ID: 16670294
[TBL] [Abstract][Full Text] [Related]
10. Priming of lineage-specifying genes by Bcl11b is required for lineage choice in post-selection thymocytes.
Kojo S; Tanaka H; Endo TA; Muroi S; Liu Y; Seo W; Tenno M; Kakugawa K; Naoe Y; Nair K; Moro K; Katsuragi Y; Kanai A; Inaba T; Egawa T; Venkatesh B; Minoda A; Kominami R; Taniuchi I
Nat Commun; 2017 Sep; 8(1):702. PubMed ID: 28951542
[TBL] [Abstract][Full Text] [Related]
11. Transcription factor Bcl11b controls selection of invariant natural killer T-cells by regulating glycolipid presentation in double-positive thymocytes.
Albu DI; VanValkenburgh J; Morin N; Califano D; Jenkins NA; Copeland NG; Liu P; Avram D
Proc Natl Acad Sci U S A; 2011 Apr; 108(15):6211-6. PubMed ID: 21444811
[TBL] [Abstract][Full Text] [Related]
12. Alteration of Bcl11b upon stimulation of both the MAP kinase- and Gsk3-dependent signaling pathways in double-negative thymocytes.
Selman WH; Esfandiari E; Filtz TM
Biochem Cell Biol; 2019 Apr; 97(2):201-213. PubMed ID: 30352171
[TBL] [Abstract][Full Text] [Related]
13. Tcrδ translocations that delete the Bcl11b haploinsufficient tumor suppressor gene promote atm-deficient T cell acute lymphoblastic leukemia.
Ehrlich LA; Yang-Iott K; Bassing CH
Cell Cycle; 2014; 13(19):3076-82. PubMed ID: 25486566
[TBL] [Abstract][Full Text] [Related]
14. Transcription Factor Bcl11b Controls Identity and Function of Mature Type 2 Innate Lymphoid Cells.
Califano D; Cho JJ; Uddin MN; Lorentsen KJ; Yang Q; Bhandoola A; Li H; Avram D
Immunity; 2015 Aug; 43(2):354-68. PubMed ID: 26231117
[TBL] [Abstract][Full Text] [Related]
15. Critical role of Bcl11b in suppressor function of T regulatory cells and prevention of inflammatory bowel disease.
Vanvalkenburgh J; Albu DI; Bapanpally C; Casanova S; Califano D; Jones DM; Ignatowicz L; Kawamoto S; Fagarasan S; Jenkins NA; Copeland NG; Liu P; Avram D
J Exp Med; 2011 Sep; 208(10):2069-81. PubMed ID: 21875956
[TBL] [Abstract][Full Text] [Related]
16. Cell of origin in radiation-induced premalignant thymocytes with differentiation capability in mice conditionally losing one Bcl11b allele.
Go R; Hirose S; Katsuragi Y; Obata M; Abe M; Mishima Y; Sakimura K; Kominami R
Cancer Sci; 2013 Aug; 104(8):1009-16. PubMed ID: 23663453
[TBL] [Abstract][Full Text] [Related]
17. Bcl11b prevents catastrophic autoimmunity by controlling multiple aspects of a regulatory T cell gene expression program.
Hasan SN; Sharma A; Ghosh S; Hong SW; Roy-Chowdhuri S; Im SH; Kang K; Rudra D
Sci Adv; 2019 Aug; 5(8):eaaw0706. PubMed ID: 31457081
[TBL] [Abstract][Full Text] [Related]
18. A far downstream enhancer for murine Bcl11b controls its T-cell specific expression.
Li L; Zhang JA; Dose M; Kueh HY; Mosadeghi R; Gounari F; Rothenberg EV
Blood; 2013 Aug; 122(6):902-11. PubMed ID: 23741008
[TBL] [Abstract][Full Text] [Related]
19. Down regulation of BCL11B expression inhibits proliferation and induces apoptosis in malignant T cells by BCL11B-935-siRNA.
Huang X; Chen S; Shen Q; Chen S; Yang L; Grabarczyk P; Przybylski GK; Schmidt CA; Li Y
Hematology; 2011 Jul; 16(4):236-42. PubMed ID: 21756541
[TBL] [Abstract][Full Text] [Related]
20. Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1.
Nagel S; Scherr M; Kel A; Hornischer K; Crawford GE; Kaufmann M; Meyer C; Drexler HG; MacLeod RA
Cancer Res; 2007 Feb; 67(4):1461-71. PubMed ID: 17308084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
